Athersys Inc. (Nasdaq: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (MSB: ASX), Osiris (Nasdaq: OSIR) and ThermoGenesis Corp (Nasdaq: KOOL), recently announced that its CEO would deliver the keynote address at the World Stem Cell Summit 2011.
Recent Posts
- Scientists discover how hair cells can help heal skin faster
- Engineered Bone Marrow Model Advances CRISPR-CAR T Research in AML
- Stem Cells Prevent Heart Failure After Heart Attack
- We need to start thinking of AI as “normal”
- Anti-fibrotic effect of human amniotic fluid stem cells in biliary epithelial-mesenchymal transition of liver ductal organoid
- Stanford makes stem cell transplants safer without chemo
